Stevanato Group
Stevanato Group SpA is an Italian global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical and life sciences industries. The company manufactures glass vials, pre-fillable syringes, cartridges, EZ-fill primary containment systems, and automated glass processing machinery under brands like Ompi and Spami. Main revenue drivers comprise global commercial sales of high-value glass primary containment systems, pre-fillable syringes, drug delivery devices, and engineering equipment. Stevanato Group serves multinational biopharmaceutical corporations, biotech startups, and contract development and manufacturing organizations (CDMOs) across Europe, North America, and Asia. The enterprise holds a world-dominant market position in glass primary containment solutions and pre-fillable drug delivery components. Headquartered in Piombino Dese, Padua, Italy, Stevanato Group SpA is listed on the New York Stock Exchange.
3 of the funds FundTelligence covers report a position in Stevanato Group.
- Legal name
- Stevanato Group SpA
- Sector
- Health Care
- Country
- Italy
- Funds holding it
- 3
Funds holding Stevanato Group
- Schroder ISF Global Smaller Companies — Schroders · 0.91 % (full portfolio disclosed, June 2026)
- DNB Health Care — DNB · 0.67 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)